Search for: "Rachel Sachs" Results 1 - 20 of 130
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
Innovation Law and COVID-19: Promoting Incentives and Access for New Healthcare Technologies
12 Oct 2021, 2:00 am by Katharine Van Tassel
Rachel Sachs (Washington University in Saint Louis) Lisa Larrimore Ouellette (Stanford University) W. [read post]
Health Law Prof Blog - http://lawprofessors.typepad.com/healthlawprof_blog/
How does the CDC’s Advisory Committee on Immunization Practices impact innovation and access to COVID-19 vaccines?
27 Aug 2021, 12:18 pm by Lisa Larrimore Ouellette
By Rachel Sachs, Jacob S. [read post]
Written Description - http://writtendescription.blogspot.com/
How does the CDC’s Advisory Committee on Immunization Practices impact innovation and access to COVID-19 vaccines?
27 Aug 2021, 12:18 pm by Lisa Larrimore Ouellette
By Rachel Sachs, Jacob S. [read post]
Written Description - http://writtendescription.blogspot.com/
What’s happening with proposals for a WTO waiver of COVID-related IP?
30 Jul 2021, 5:03 am by Lisa Larrimore Ouellette
By Nicholson Price, Rachel Sachs, Jacob S. [read post]
Written Description - http://writtendescription.blogspot.com/
What’s happening with proposals for a WTO waiver of COVID-related IP?
30 Jul 2021, 5:03 am by Lisa Larrimore Ouellette
By Nicholson Price, Rachel Sachs, Jacob S. [read post]
Written Description - http://writtendescription.blogspot.com/
Encouraging Interagency Collaboration: Learning from COVID-19
30 Jul 2021, 2:00 am by Katharine Van Tassel
Rachel Sachs (Washington University in Saint Louis), Encouraging Interagency Collaboration: Learning from COVID-19, J. [read post]
Health Law Prof Blog - http://lawprofessors.typepad.com/healthlawprof_blog/
Why do differences in clinical trial design make it hard to compare COVID-19 vaccines?
30 Jun 2021, 10:31 am by Lisa Larrimore Ouellette
By Lisa Larrimore Ouellette, Nicholson Price, Rachel Sachs, and Jacob S. [read post]
Written Description - http://writtendescription.blogspot.com/
Why do differences in clinical trial design make it hard to compare COVID-19 vaccines?
30 Jun 2021, 10:31 am by Lisa Larrimore Ouellette
By Lisa Larrimore Ouellette, Nicholson Price, Rachel Sachs, and Jacob S. [read post]
Written Description - http://writtendescription.blogspot.com/
Sachs testifies before House committee
5 May 2021, 12:45 pm by Neil Schoenherr
Sachs Rachel Sachs, associate professor of law at Washington University School of Law in St. [read post]
WUSTL School of Law News - https://source.wustl.edu/schools/school-of-law/
What can policymakers learn from the UK’s RECOVERY trial to improve clinical research for COVID-19 and beyond?
3 May 2021, 8:36 am by Lisa Larrimore Ouellette
By Rachel Sachs, Jacob S. [read post]
Written Description - http://writtendescription.blogspot.com/
What can policymakers learn from the UK’s RECOVERY trial to improve clinical research for COVID-19 and beyond?
3 May 2021, 8:36 am by Lisa Larrimore Ouellette
By Rachel Sachs, Jacob S. [read post]
Written Description - http://writtendescription.blogspot.com/
[Eugene Volokh] Dr. Luke Isn't a Public Figure for Purposes of His Libel Lawsuit Against Ke$ha
23 Apr 2021, 10:07 am by Eugene Volokh
The complaint alleges that in 2012 and 2013 Kesha and her agents ([her mother Pebe Sebert], nonparties Mark Geragos and Kenneth Meiselas—her then attorneys—and Sunshine Sachs, her newly retained public relations firm) sought to end her agreement with Gottwald so she could derive a larger share of profits from any future records…. [read post]
The Volokh Conspiracy - http://www.volokh.com/
How can Congress create infrastructure for the next pandemic?
9 Apr 2021, 8:03 am by Lisa Larrimore Ouellette
By Nicholson Price, Rachel Sachs, Jacob S. [read post]
Written Description - http://writtendescription.blogspot.com/
How can Congress create infrastructure for the next pandemic?
9 Apr 2021, 8:03 am by Lisa Larrimore Ouellette
By Nicholson Price, Rachel Sachs, Jacob S. [read post]
Written Description - http://writtendescription.blogspot.com/
How are COVID-19 vaccine developers and regulators responding to variants?
25 Mar 2021, 1:24 pm by Lisa Larrimore Ouellette
By Lisa Larrimore Ouellette, Nicholson Price, Rachel Sachs, and Jacob S. [read post]
Written Description - http://writtendescription.blogspot.com/
How are COVID-19 vaccine developers and regulators responding to variants?
25 Mar 2021, 1:24 pm by Lisa Larrimore Ouellette
By Lisa Larrimore Ouellette, Nicholson Price, Rachel Sachs, and Jacob S. [read post]
Written Description - http://writtendescription.blogspot.com/
New Innovation Models in Medical AI
20 Mar 2021, 2:00 am by Katharine Van Tassel
Nicholson Price II (University of Michigan), Rachel Sachs (Washington University in Saint Louis), Rebecca S. [read post]
Health Law Prof Blog - http://lawprofessors.typepad.com/healthlawprof_blog/
How can policymakers overcome the hurdles to scaling up antibody manufacturing?
18 Feb 2021, 10:24 am by Lisa Larrimore Ouellette
By Rachel Sachs, Jacob S. [read post]
Written Description - http://writtendescription.blogspot.com/
How can policymakers overcome the hurdles to scaling up antibody manufacturing?
18 Feb 2021, 10:24 am by Lisa Larrimore Ouellette
By Rachel Sachs, Jacob S. [read post]
Written Description - http://writtendescription.blogspot.com/
Why aren’t therapeutic antibodies being used more to treat COVID-19?
29 Jan 2021, 10:26 am by Lisa Larrimore Ouellette
By Nicholson Price, Rachel Sachs, Jacob S. [read post]
Written Description - http://writtendescription.blogspot.com/